Cargando…
Reduced Serum Levels of Bone Formation Marker P1NP in Psoriasis
Psoriasis is a chronic inflammatory disease of the skin and joints. More recent data emphasize an association with dysregulated glucose and fatty acid metabolism, obesity, elevated blood pressure and cardiac disease, summarized as metabolic syndrome. TNF-α and IL-17, central players in the pathogene...
Autores principales: | Mentzel, Julia, Kynast, Tabea, Kohlmann, Johannes, Kirsten, Holger, Blüher, Matthias, Simon, Jan C., Kunz, Manfred, Saalbach, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517119/ https://www.ncbi.nlm.nih.gov/pubmed/34660638 http://dx.doi.org/10.3389/fmed.2021.730164 |
Ejemplares similares
-
Impact of Chronic Inflammation in Psoriasis on Bone Metabolism
por: Saalbach, Anja, et al.
Publicado: (2022) -
Psoriasis: Obesity and Fatty Acids
por: Kunz, Manfred, et al.
Publicado: (2019) -
Editorial: Metabolic conditions of chronic inflammatory diseases
por: Saalbach, Anja, et al.
Publicado: (2022) -
Modulation of Dietary Fatty Acids in an Open-Label Study Improves Psoriasis and Dampens the Inflammatory Activation Status
por: Saalbach, Anja, et al.
Publicado: (2023) -
Interleukin-6 May Not Affect Bone Resorption Marker CTX or Bone Formation Marker P1NP in Humans
por: Lehrskov, Louise L, et al.
Publicado: (2020)